相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group
Mathew S. Maurer et al.
CIRCULATION-HEART FAILURE (2022)
Development of a conceptual model of patient-reported outcomes in light chain amyloidosis: a qualitative study
Anita D'Souza et al.
QUALITY OF LIFE RESEARCH (2022)
Changes in patient-reported outcomes in light chain amyloidosis in the first year after diagnosis and relationship to NT-proBNP change
Anita D'Souza et al.
BLOOD CANCER JOURNAL (2021)
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
E. Kastritis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The use of PROMIS patient-reported outcomes (PROs) to inform light chain (AL) amyloid disease severity at diagnosis
Anita D'Souza et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2020)
High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis
Vaishali Sanchorawala
ACTA HAEMATOLOGICA (2020)
Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis
Amanda Schulman et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis
Isabelle Lousada
ORPHANET JOURNAL OF RARE DISEASES (2020)
The Impact of AL Amyloidosis The Patient Experience
Isabelle Lousada et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2020)
High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review
Cindy Varga et al.
BONE MARROW TRANSPLANTATION (2019)
A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing
Eli Muchtar et al.
MAYO CLINIC PROCEEDINGS (2019)
Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis
Kristen L. McCausland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
PROMISA (R)-29 v2.0 profile physical and mental health summary scores
Ron D. Hays et al.
QUALITY OF LIFE RESEARCH (2018)
Systemic immunoglobulin light chain amyloidosis
Giampaolo Merlini et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Epidemiology of AL amyloidosis: a real-world study using US claims data
Tiffany P. Quock et al.
BLOOD ADVANCES (2018)
Light Chain (AL) Amyloidosis: The Journey to Diagnosis
Kristen L. McCausland et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2018)
The burden of amyloid light chain amyloidosis on health-related quality of life
Martha Bayliss et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Patient-Reported Outcome and Observer-Reported Outcome Assessment in Rare Disease Clinical Trials: An ISPOR COA Emerging Good Practices Task Force Report
Katy Benjamin et al.
VALUE IN HEALTH (2017)
Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples
Michelle K. White et al.
PATIENT-RELATED OUTCOME MEASURES (2017)
A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time
Vaishali Sanchorawala et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Disease burden of systemic light-chain amyloidosis: a systematic literature review
Huamao Mark Lin et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients
Janet Shu et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2016)
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium
Isabelle Lousada et al.
ADVANCES IN THERAPY (2015)
The patient's perspective on the symptom and everyday life impact of AL amyloidosis
Huamao Mark Lin et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2015)
AL Amyloidosis
Estelle Desport et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
MA Gertz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2005)
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation
DC Seldin et al.
BLOOD (2004)